Commodore Capital’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $70.2M | Buy |
|
|||||
|
2025
Q1 | $58.1M | Buy |
|
|||||
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $55M | Buy |
|
|||||
|
2024
Q2 | $52.7M | Buy |
|
|||||
|
2024
Q1 | $36.4M | Buy |
|
|||||
|
2023
Q4 | $27.8M | Sell |
|
|||||
|
2023
Q3 | $19.4M | Buy |
|
|||||
|
2023
Q2 | $21.4M | Buy |
|
|||||
|
2023
Q1 | $17.8M | Hold |
|
|||||
|
2022
Q4 | $22.1M | Sell |
|
|||||
|
2022
Q3 | $15.1M | Hold |
|
|||||
|
2022
Q2 | $14.5M | Buy |
|
|||||
|
2022
Q1 | $8.21M | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $13.4M | Sell |
|
|||||
|
2021
Q2 | $10.8M | Sell |
|
|||||
|
2021
Q1 | $7.62M | Buy |
|
|||||
|
2020
Q4 | $6.25M | Buy |
|